Nonfunctioning pituitary tumors
- PMID: 25248587
- DOI: 10.1016/B978-0-444-59602-4.00012-5
Nonfunctioning pituitary tumors
Abstract
Clinically nonfunctioning adenomas range from being completely asymptomatic, and therefore detected either at autopsy or as incidental findings on head MRI or CT scans performed for other reasons, to causing significant hypothalamic/pituitary dysfunction and visual field compromise due to their large size. Patients with incidental adenomas should be screened for hypersecretion (prolactin, insulin-like growth factor 1, midnight salivary cortisol) and for hypopituitarism (macroadenomas). In the absence of hypersecretion, hypopituitarism, or visual field defects, patients may be followed by periodic screening by MRI for enlargement, at which point surgery may be necessary. Symptomatic patients with clinically nonfunctioning adenomas are generally treated by transsphenoidal surgery. Postoperative MRIs are done at 3-4 months after surgery to assess for completeness of resection and then repeated yearly for 3-5 years and subsequently less frequently to assess for regrowth. For those with no visible tumor on MRI, the tumor regrowth rate is about 13% and such patients may be followed with periodic MRIs. For those with visible tumor, the tumor regrowth rate is about 40%. This regrowth rate may be substantially reduced with the use of dopamine agonists and radiotherapy.
Keywords: Adenoma; nonfunctioning; pituitary; radiotherapy; transsphenoidal; tumor; “incidentaloma”.
© 2014 Elsevier B.V. All rights reserved.
Similar articles
-
Nonfunctioning pituitary tumors and pituitary incidentalomas.Endocrinol Metab Clin North Am. 2008 Mar;37(1):151-71, xi. doi: 10.1016/j.ecl.2007.10.011. Endocrinol Metab Clin North Am. 2008. PMID: 18226735 Review.
-
Pituitary tumours: pituitary incidentalomas.Best Pract Res Clin Endocrinol Metab. 2009 Oct;23(5):667-75. doi: 10.1016/j.beem.2009.05.001. Best Pract Res Clin Endocrinol Metab. 2009. PMID: 19945030 Review.
-
Management of incidentally found nonfunctional pituitary tumors.Neurosurg Clin N Am. 2012 Oct;23(4):543-53. doi: 10.1016/j.nec.2012.06.003. Epub 2012 Jul 31. Neurosurg Clin N Am. 2012. PMID: 23040742 Review.
-
Management of nonfunctioning pituitary adenomas (NFAs): observation.Pituitary. 2018 Apr;21(2):162-167. doi: 10.1007/s11102-017-0856-0. Pituitary. 2018. PMID: 29280025 Review.
-
Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma.J Neurosurg. 2014 Nov;121(5):1166-75. doi: 10.3171/2014.6.JNS131994. Epub 2014 Aug 15. J Neurosurg. 2014. PMID: 25127413
Cited by
-
Mammalian Ste20-like kinase 4 promotes pituitary cell proliferation and survival under hypoxia.Mol Endocrinol. 2015 Mar;29(3):460-72. doi: 10.1210/me.2014-1332. Epub 2015 Feb 4. Mol Endocrinol. 2015. PMID: 25650755 Free PMC article.
-
Pituitary adenomas: biology, nomenclature and clinical classification.Rev Endocr Metab Disord. 2025 Apr;26(2):137-146. doi: 10.1007/s11154-025-09944-x. Epub 2025 Jan 25. Rev Endocr Metab Disord. 2025. PMID: 39862335 Review.
-
Pituitary incidentaloma: a Pituitary Society international consensus guideline statement.Nat Rev Endocrinol. 2025 Jun 24. doi: 10.1038/s41574-025-01134-8. Online ahead of print. Nat Rev Endocrinol. 2025. PMID: 40555795 Review.
-
Usefulness of an ad hoc questionnaire (Acro-CQ) for the systematic assessment of acromegaly comorbidities at diagnosis and their management at follow-up.J Endocrinol Invest. 2016 Nov;39(11):1277-1284. doi: 10.1007/s40618-016-0476-y. Epub 2016 May 6. J Endocrinol Invest. 2016. PMID: 27153851
-
Growth of Pituitary Macroadenomas Postpartial Resection: Implications for Adjuvant Radiotherapy.J Neurol Surg B Skull Base. 2019 Jun;80(3):323-326. doi: 10.1055/s-0038-1670686. Epub 2018 Oct 10. J Neurol Surg B Skull Base. 2019. PMID: 31143578 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical